Sign Up Today and Learn More About IgGenix Stock
Invest in or calculate the value of your shares in IgGenix or other pre-IPO companies through EquityZen's platform.
About IgGenix Stock
Founded
2019
Headquarters
San Francisco, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
IgGenix Press Mentions
Stay in the know about the latest news on IgGenix
IgGenix to Present Alpha-gal Syndrome Monoclonal Antibody Discovery at 2025 AAAAI / WAO Joint Congress
biospace • Feb 10, 2025
IgGenix to Present Alpha-gal Syndrome Monoclonal Antibody Discovery at 2025 AAAAI / WAO Joint Congress
prnewswire • Feb 10, 2025
Combinations for allergy therapy
patents • Feb 08, 2025
Compositions and methods for treating and suppressing allergic responses
patents • Feb 08, 2025
Compositions and methods for the prevention of type i hypersensitivity …
patents • Feb 08, 2025
IgGenix Management
Leadership team at IgGenix
Board Member
Joel Marcus
Chief Executive Officer
Jessica Grossman
Join now and verify your accreditation status to gain access to:
- IgGenix Current Valuation
- IgGenix Stock Price
- IgGenix Management
- Available deals in IgGenix and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- IgGenix Cap Table and Funding History by Share Class and Liquidity Preferences
- IgGenix Revenue and Financials
- IgGenix Highlights
- IgGenix Business Model
- IgGenix Risk Factors
- IgGenix Research Report from SACRA Research
Trading IgGenix Stock
How to invest in IgGenix stock?
Accredited investors can buy pre-IPO stock in companies like IgGenix through EquityZen funds. These investments are made available by existing IgGenix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell IgGenix stock?
Shareholders can sell their IgGenix stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
